Valuation AstraZeneca PLC Nasdaq Stockholm

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-31 EDT			5-day change	1st Jan Change
1,627.50 ^SEK	-0.34%		-1.36%	-4.46%

07-31	EU Approves AstraZeneca and Daiichi Sankyo's Datroway for First-Line Triple-Negative Breast Cancer	MT
07-31	Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	263,738	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-8.36%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	283,792	276,300	268,459
Change	-	12.57%	-0.25%	-1.74%	36.64%	-8.8%	-2.64%	-2.84%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.8x	19x	16.5x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.89x	4.35x	3.69x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.3x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.17x	3.95x	3.7x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.48x	4.13x	3.76x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.7x	11.3x	10x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.5x	11.9x	10.5x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	29.6x	21.3x	18.7x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.38%	4.69%	5.35%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.325	3.527	3.662
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.96%	2.07%	2.15%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.815	8.959	10.33
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.5%	39.4%	35.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,281	66,853	71,311
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,338	24,438	26,859
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,092	23,272	25,589
Net income ¹	112	3,288	5,961	7,035	10,225	12,085	13,710	15,677
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	20,054	12,563	4,722
Reference price ²	117.51	135.16	135.02	131.05	185.60	170.04	170.04	170.04
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.3x	12.25x	25.74x	0.59%	1,030B
JOHNSON & JOHNSON	27.42x	6.27x	17.37x	2.1%	617B
ABBVIE INC.	32.4x	7.6x	15.6x	2.67%	455B
ROCHE HOLDING AG	19.58x	4.68x	11.59x	2.83%	350B
NOVARTIS AG	22.31x	5.76x	14.38x	2.78%	299B
NOVO NORDISK A/S	14.62x	5.41x	11.16x	3.43%	225B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.31x	5.67x	31.32x	2.51%	163B
PFIZER INC.	12.64x	3.1x	7.83x	6.91%	142B
Average	15.71x	6.38x	16.30x	2.94%	387.71B
Weighted average by Cap.	23.84x	7.82x	18.30x	2.19%